|
|
|||||||||
AAP Grand Rounds 18:66-67 (2007)
© 2007 American Academy of Pediatrics
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome, first described by Marshall1 in 1987, is the commonest type of periodic fever among children. Episodes of PFAPA are characterized by periodic high fever lasting three to six days and recurring every three to eight weeks, often accompanied by aphthous stomatitis, pharyngitis, and adenitis. Treatment with antipyretics and antibiotics has been ineffective.2 A single high dose of corticosteroid (prednisone 1–2 mg/kg) frequently leads to rapid resolution of the fever3 but does not prevent subsequent episodes. The only therapies reported to reduce recurrence of episodes are continuous cimetidine therapy4 and tonsillectomy,5 but no controlled studies of either have been published.
Investigators from the Universities of Oulu, Helsinki, and Turku in Finland carried out a prospective, randomized, controlled trial to clarify the effect of tonsillectomy on the clinical course of PFAPA syndrome. Consecutive children with at least five PFAPA attacks were recruited from three tertiary care pediatric hospitals between 1999 and 2003. Criteria for an attack included high fever (>38.5°C) of unknown origin recurring in a typical regular pattern and asymptomatic intervals of two to five weeks. Participants were randomly assigned to either the treatment group (tonsillectomy performed within one month of enrollment) or the control group. They were all followed up with symptom diaries to be completed by parents. Accompanying signs of aphthous stomatitis, pharyngitis, and adenitis were recorded.
Twenty-eight children (mean age of four years) were initially enrolled and found to have an average of nine febrile episodes (range 4–20) before recruitment, with fever lasting a mean of 3.6 days (range 2–6) and a mean interval between episodes of 25.6 days (range 18–28). In 41% of the children, fever was the only finding during each recurrent episode. Twenty-nine percent had exudative tonsillitis during at least one of the episodes, and 21% had either aphthous stomatitis, cervical adenitis, or pain in the mouth or throat during at least one episode. Two children were excluded from analysis: one developed leukemia during follow-up and the second was lost to follow-up.
All 14 children in the tonsillectomy group and six of 12 (50%) in the control group were free of symptoms (as defined by disappearance of fever episodes) six months after randomization (P<.001). Tonsillectomy was performed on five of the 12 children in the control group after the follow-up period of six months because symptoms persisted, after which the symptoms disappeared in all five cases for the duration of the one-year follow-up period. The six children in the control group who were better without tonsillectomy did not differ from the six in whom the attacks recurred with regard to age, sex, or features of the PFAPA attacks. The authors conclude that tonsillectomy is an effective therapeutic option for children with PFAPA.
|
Commentary by
|
|---|
|
1 University of Colorado School of Medicine and The Childrens Hospital, Denver, CO 2 Pediatrics, University of Arizona School of Medicine, Tucson, AZ |
As previously discussed in these pages (see
AAP Grand Rounds, October 1999;2:39–40
| References |
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |